-
2
-
-
0027281155
-
Sweet's syndrome and cancer
-
DOI 10.1016/0738-081X(93)90112-P
-
Cohen PR, Kurzrock R. Sweet's syndrome and cancer. Clin Dermatol 1993;11:149-157 (Pubitemid 23191681)
-
(1993)
Clinics in Dermatology
, vol.11
, Issue.1
, pp. 149-157
-
-
Cohen, P.R.1
Kurzrock, R.2
-
3
-
-
0023712236
-
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum
-
DOI 10.1002/art.1780310816
-
Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-1045 (Pubitemid 18207972)
-
(1988)
Arthritis and Rheumatism
, vol.31
, Issue.8
, pp. 1041-1045
-
-
Saxne, T.1
Palladino Jr., M.A.2
Heinegard, D.3
Talal, N.4
Wollheim, F.A.5
-
4
-
-
0026091413
-
Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis
-
Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-1132
-
(1991)
Arthritis Rheum
, vol.34
, pp. 1125-1132
-
-
Chu, C.Q.1
Field, M.2
Feldmann, M.3
Maini, R.N.4
-
5
-
-
0029045924
-
Association between degree of bone erosion and synovial fluid levels of tumor necrosis factor alpha in the knee-joints of patients with rheumatoid arthritis
-
Neidel J, Schulze M, Lindschau J. Association between degree of bone erosion and synovial fluid levels of tumor necrosis factor alpha in the knee-joints of patients with rheumatoid arthritis. Inflamm Res 1995;44:217-221
-
(1995)
Inflamm Res
, vol.44
, pp. 217-221
-
-
Neidel, J.1
Schulze, M.2
Lindschau, J.3
-
6
-
-
8044257704
-
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells
-
DOI 10.1038/385729a0
-
Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997;385:729-733 (Pubitemid 27098094)
-
(1997)
Nature
, vol.385
, Issue.6618
, pp. 729-733
-
-
Black, R.A.1
Rauch, C.T.2
Kozlosky, C.J.3
Peschon, J.J.4
Slack, J.L.5
Wolfson, M.F.6
Castner, B.J.7
Stocking, K.L.8
Reddy, P.9
Srinivasan, S.10
Nelson, N.11
Boiani, N.12
Schooley, K.A.13
Gerhart, M.14
Davis, R.15
Fitzner, J.N.16
Johnson, R.S.17
Paxton, R.J.18
March, C.J.19
Cerretti, D.P.20
more..
-
8
-
-
32644449004
-
Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept [2]
-
DOI 10.1016/j.jaad.2005.10.055, PII S0190962205045779
-
Yamauchi PS, Turner L, Lowe NJ, Gindi V, Jackson MJ. Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 2006;54:S122-6. (Pubitemid 43243484)
-
(2006)
Journal of the American Academy of Dermatology
, vol.54
, Issue.3 SUPPL. 2
-
-
Yamauchi, P.S.1
Lowe, N.J.2
Gindi, V.3
-
9
-
-
0036123608
-
Traitement d'un syndrome de Sweet et d'un erytheme noueux compliquant une maladie de Crohn par anti-TNF (infliximab)
-
Vanbiervliet G, Anty R, Schneider S, Arab K, Rampal P, Hebuterne X. Sweet's syndrome and erythema nodosum associated with Crohn's disease treated by infliximab. Gastroenterol Clin Biol 2002;26:295-297 (Pubitemid 34408024)
-
(2002)
Gastroenterologie Clinique et Biologique
, vol.26
, Issue.3
, pp. 295-297
-
-
Vanbiervliet, G.1
Anty, R.2
Schneider, S.3
Arab, K.4
Rampal, P.5
Hebuterne, X.6
-
10
-
-
33646696885
-
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
-
DOI 10.1001/jama.295.19.2275
-
Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-2285 (Pubitemid 43736578)
-
(2006)
Journal of the American Medical Association
, vol.295
, Issue.19
, pp. 2275-2285
-
-
Bongartz, T.1
Sutton, A.J.2
Sweeting, M.J.3
Buchan, I.4
Matteson, E.L.5
Montori, V.6
-
11
-
-
12544253745
-
Etanercept plus standard therapy for Wegener's granulomatosis
-
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
-
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005;352:351-361
-
(2005)
N Engl J Med
, vol.352
, pp. 351-361
-
-
-
12
-
-
0024247486
-
Malignancy-associated Sweet's syndrome: Review of the world literature
-
Cohen PR, Talpez M, Kurzrock R. Malignancy associated Sweet's syndrome. Review of world literature. J Clin Oncol 1988;6:1887. (Pubitemid 19089073)
-
(1988)
Journal of Clinical Oncology
, vol.6
, Issue.12
, pp. 1887-1897
-
-
Cohen, P.R.1
Talpaz, M.2
Kurzrock, R.3
-
13
-
-
0027422070
-
Sweet syndrome in patients with solid tumors
-
DOI 10.1002/1097-0142(19931101)72:9<2723::AID-CNCR2820720933>3.0. CO;2-F
-
Cohen PR, Holder WR, Tucker SB, et al. Sweet's syndrome patients with solid tumors. Cancer 1993;72:2723-2731 (Pubitemid 23320239)
-
(1993)
Cancer
, vol.72
, Issue.9
, pp. 2723-2731
-
-
Cohen, P.R.1
Holder, W.R.2
Tucker, S.B.3
Kono, S.4
Kurzrock, R.5
|